Retatrutide vs Tirzepatide
Side-by-side comparison of peptide medications.
| Feature | Retatrutide | Tirzepatide |
|---|---|---|
| Category | weight-loss | weight-loss |
| Administration | Subcutaneous injection (weekly) | Subcutaneous injection (weekly) |
| Prescription Required | Yes | Yes |
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 3 clinical trials show weight loss exceeding tirzepatide, positioning it as the most potent anti-obesity peptide in development.
Common uses: Weight loss, Metabolic health, Appetite suppression, Blood sugar regulation
Tirzepatide
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.
Common uses: Weight loss, Type 2 diabetes management, Metabolic health